NODAT and Risk of Cardiovascular-Related Mortality There is increased risk of cardiovascular complications in patients who develop new-onset diabetes after transplantation (NODAT). Further, despite the use of a steroid sparing immunosuppressive regimen, patients who develop NODAT have reduced survival. Moutzouris, MD, and colleagues at the Imperial College Renal and Transplant Centre in London, United Kingdom, recently conducted a retrospective, single-center ... Read More »

Post-Transplant Immunosuppressive AEs Scoring System Validated

Patient safety and immunosuppressive adherence post-transplant may be improved utilizing a clinician administered immunosuppressive adverse effects (AEs) scoring system that was validated in a recent study conducted by Calvin J. Meaney, PharmD, et al. Study findings were reported in BMC Nephrology [doi:10.1186/1471-2369-15-88]. Compared with chronic dialysis, renal transplantation is the preferred intervention for patients with end-stage renal disease. To prevent ... Read More »